Market research dominates early-phase spending
Pharmaceutical companies are spending big on market research during the early stages of drug discovery.
Archives for August 17, 2006
Ariad issued with cancer drug patent
Ariad Pharmaceuticals has been issued with a patent that covers the novel use of mTOR inhibitors that are designed for the treatment of cancers including soft-tissue and bone sarcomas; prostate, breast, pancreatic, brain, lung and colon cancers; and...